TY  - JOUR
T1  - PRescription drug monitoring programs—reply
AU  - Gugelmann HM, Perrone J
Y1  - 2012/03/07
N1  - 10.1001/jama.307.9.912-c
JO  - JAMA
SP  - 912
EP  - 913
VL  - 307
IS  - 9
N2  - 
Like Yokell et al, we have also noted—both in our own clinical practice and in that of colleagues—that real-time access to prescription databases for health professionals facilitates a patient-centered approach to addressing opioid abuse. In addition, we have encountered physicians managing chronic opioid therapy who are more comfortable checking a prescription monitoring program report than mandating urine drug screening, which requires awkward patient confrontation and can result in disruption of the patient-physician alliance.1

SN  - 0098-7484
M3  - doi: 10.1001/jama.307.9.912-c
UR  - http://dx.doi.org/10.1001/jama.307.9.912-c
ER  -